coenzyme Q10Finding
Source withdrawn and superseded by an update. Do not rely on it.
Coenzyme Q10 has no detected effect on withdrawal due to adverse events
no difference foundVery limited evidenceFinding
01 · The sentence it was drawn from
“In safety outcomes, only the risk ratios (RR) of pharyngitis (RR 1.04, 95% CI 0.18 to 5.89) and diarrhea (RR 1.39, 95% CI 0.62 to 3.16) are mild elevated between coenzyme Q10 therapy and placebo and there were no differences in the number of withdrawals due to adverse effects (RR 0.61, 95% CI 0.23 to 1.62).”
coenzyme Q10
Withdrawal due to adverse events
no difference found
Effect as reported
0.61risk ratio
CI 0.23 to 1.62
- Who
- patients with early and midstage Parkinson's disease; Cochrane meta-analysis of 4 RCTs, 452 patients, coenzyme Q10 versus placebo
- Dose studied
- 1200 mg/d for 16 months
Very limited evidencePMID 22161420 · 2011
02 · The study
- Study
- meta-analysis
- Duration
- not reported
Evidence, by strength
- strong
- moderate
- limited
- very limitedthis finding
- insufficient
03 · The paper
The Cochrane database of systematic reviewsCoenzyme Q10 for Parkinson's disease.
2011PMID 22161420doi 10.1002/14651858.CD008150.pub2
04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M38RFSM3H9K69VMW49MXCEXY